Bendamustine alone effectively inhibited proliferation and induced apoptosis in ATLL cell lines, and its activity was significantly enhanced when combined with agents targeting survival pathways, including BCL-2 family proteins [56]. The gene discussed is BCL2; the disease is adult T-cell leukemia/lymphoma.